Five new chemosensors (R1–R5), possessing benzoquinone as the signaling unit and imidazole as the H-bond donor unit, for cyanide sensing have been rationally designed, synthesized and characterized by NMR and mass spectroscopy. The structure of R5 was confirmed by single crystal XRD studies. These receptors exhibited a prominent visual colour change toward the cyanide ion over other common anions in an aqueous HEPES buffer–DMF (9 : 1 v/v) medium. The complexation of receptor–CN− has been addressed by UV-Vis, fluorescence and 1H NMR spectra and was supported by electrochemical and DFT studies. The mechanism of sensing involves formation of H-bonds between imidazole N–H and CN− ions. The stoichiometry of the receptor–CN− complexes was found to be 1 : 2 (receptor–CN−) and the detection limit was observed to be in the range of 1.1–3 nM. The test strips based on R5 were fabricated and could act as convenient and efficient CN− test kits. Notably, the novelty of the present investigation is that the receptor R5 selectively senses CN− ions in solid, aqueous and gas phases i.e. ‘a complete receptor’.
Protein binding, DNA binding/cleavage and in vitro cytotoxicity studies of 2-((3-(dimethylamino)propyl)amino)naphthalene-1,4-dione (L) and its four coordinated M(II) complexes [M(II) = Co(II), Cu(II), Ni(II) and Zn(II)] have been investigated using various spectral techniques. The structure of the ligand was confirmed by spectral and single crystal XRD studies. The geometry of the complexes has been established using analytical and spectral investigations. These complexes show good binding tendency to bovine serum albumin (BSA) exhibiting high binding constant values (105 M−1) when compared to free ligand. Fluorescence titration studies reveal that these compounds bind strongly with CT-DNA through intercalative mode (Kapp 105 M−1) and follow the order: Cu(II) > Zn(II) > Ni(II) > Co(II) > L. Molecular docking study substantiate the strength and mode of binding of these compounds with DNA. All the complexes efficiently cleaved pUC18-DNA via hydroxyl radical mechanism and the Cu(II) complex degraded the DNA completely by converting supercoiled form to linear form. The complexes demonstrate a comparable in vitro cytotoxic activity against two human cancer cell lines (MCF-7 and A-549), which is comparable with that of cisplatin. AO/EB and DAPI staining studies suggest apoptotic mode of cell death, in these cancer cells, with the compounds under investigation.